Revised SPC: Ovestin (estriol) cream

SPC now states that epidemiological evidence from a large meta-analysis suggests no increased risk of breast cancer in women with no history of breast cancer taking low dose vaginal oestrogens, but it is unknown if low dose vaginal oestrogens stimulate breast cancer recurrence.

Source:

electronic Medicines compendium